Get started
Author

Hemant Suryavanshi

Observed name: Hemant R. Suryavanshi
ORCID: 0000-0001-5539-8472
Observed ORCID: 0000-0001-5539-8472
OpenAlex ID: A5040160227
Green synthesis of Ag@TiO2 nanomaterials using Achyranthes aspera leaf extract for sustainable photocatalytic degradation of dyes
2025 · Vikram Jadhav, Mukta Patil, et al. · Discover Applied Sciences · 32
PDF
Design, synthesis and biological evaluation of vortioxetine derivatives as new COX-1/2 inhibitors in human monocytes
2020 · Maria Talmon, Raju D. Chaudhari, et al. · Bioorganic & Medicinal Chemistry · 15
Design, synthesis and docking study of Vortioxetine derivatives as a SARS-CoV-2 main protease inhibitor
2022 · Hemant Suryavanshi, Raju D. Chaudhari, et al. · DARU Journal of Pharmaceutical Sciences · 11
PDF
Synthesis and In Silico Evaluation of Novel 1,2,3-Triazole Derivatives as Antibacterial Agents with Predicted Binding Affinity for Penicillin-Binding Proteins of Methicillin-Resistant Staphylococcus aureus
2026 · Hemant Suryavanshi, Sachin Kulkarni, et al. · Journal of Molecular Structure · 1
Design, Synthesis, and Inhibitory Activity of Benzimidazole‐2‐thiol Derivatives on SHSY‐5Y Neuroblastoma Cancer Cell Line
2025 · Hemant Suryavanshi, Anuruddha Chabukswar, et al. · ChemistrySelect · 1
Synthesis of novel phenol based 1, 2, 3-triazole by using the magnetically active Fe3O4.Cu2O nanocatalyst
2024 · Shaktising S. Pardeshi, Hemant R. Suryavanshi, et al. · AIP conference proceedings
Chronopharmacokinetic and Metabolites Investigations of the Cardiovascular Drugs Perindopril
2023 · Arvind Umarkar, Subhranshu Panda, et al. · International Journal of Drug Delivery Technology
PDF
Chronopharmacokinetic and Metabolite Studies of the Cardiovascular Medication Sacubitril
2023 · Arvind Umarkar, Subhranshu Panda, et al. · International Journal of Drug Delivery Technology
PDF
Works count: 8
Citation count: 60
H-index: 3
I10-index: 3
Year
Topic
Type